Pneumococcal
Key Takeaways from 2024-2025 Respiratory Season
In this recorded webinar, NFID hosts a discussion on key takeaways from the 2024-2025 US respiratory season, with a focus on influenza (flu) and more …
Harnessing the Power of Local Data
NFID dashboard aims to empower stakeholders with hyperlocal data to increase US adult respiratory vaccine uptake
New Collaboration Aims to Empower Black Communities to Help Protect against Preventable Respiratory Diseases
NFID partners with National Council of Negro Women Good Health WINs to raise awareness about COVID-19, flu, pneumococcal disease, and RSV
Adults Age 50 and Older Can Help Lower Risk for Pneumonia
NFID and the American Lung Association are working together to raise awareness about the importance of pneumococcal disease vaccination for those at risk
Is It Flu, COVID-19, or RSV? How to Tell the Difference
Is it a cold that is causing your cough or runny nose? Or could it be something potentially more serious? Although symptoms can be similar, treatment options may differ …
Preparing for Respiratory Season
In this recorded webinar, speakers discuss the importance of vaccination to help protect against severe illness during the US respiratory season
Help Prevent Flu, COVID-19, and RSV This Season
NFID and CDC experts urge vaccination to help protect against COVID-19, flu, pneumococcal disease, and RSV …
2024 National Survey: Attitudes and Behaviors about Influenza, COVID-19, Respiratory Syncytial Virus, and Pneumococcal Disease
2024 national survey on flu, RSV, COVID-19, and pneumococcal disease
As Concerns about Respiratory Diseases Among Public Drop to New Lows, US Health Officials Urge Vaccination
New NFID survey shows fewer than 1 in 5 US adults are concerned about flu, COVID-19, RSV, or pneumococcal disease, and many do not plan to get vaccinated this fall and winter
2024 NFID Annual News Conference: Preventing Respiratory Disease This Fall and Winter
Leading public health officials to present new data and national survey findings